We are live on ! Find out more
SID icon

Companhia Siderúrgica Nacional

1.27 USD
-0.11
7.97%
At close Updated Sep 11, 4:00 PM EDT
Pre-market
After hours
1.24
-0.03
2.36%
1 day
-7.97%
5 days
3.25%
1 month
46.55%
3 months
4.96%
6 months
-7.97%
Year to date
-21.12%
1 year
-13.01%
5 years
-80.19%
10 years
-51.89%
 

About: Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations port concessions and fleets of road transport vehicles. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

Employees: 29,664

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 20%
Neutral 40%
Negative 40%
Negative
Zacks Investment Research
27 days ago
SID Q2 Earnings Miss on Higher Financial Costs, Revenues Rise Y/Y
National Steel's Q2 loss misses estimates despite higher revenues, as stronger steel, energy and cement results are offset by financial costs.
SID Q2 Earnings Miss on Higher Financial Costs, Revenues Rise Y/Y
Positive
MarketBeat
1 month ago
National Steel Q2 Earnings Call Highlights
National Steel NYSE: SID, also known as CSN, reported higher consolidated EBITDA in the second quarter of 2026, supported by improved commercial performance across its steel, cement, logistics and energy businesses, while management continued to emphasize asset sales, working-capital reductions and debt-management initiatives.
National Steel Q2 Earnings Call Highlights
Neutral
Seeking Alpha
1 month ago
Companhia Siderúrgica Nacional (SID) Q2 2026 Earnings Call Transcript
Companhia Siderúrgica Nacional (SID) Q2 2026 Earnings Call Transcript
Companhia Siderúrgica Nacional (SID) Q2 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures' Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation
São Paulo, July 30, 2026 (GLOBE NEWSWIRE) -- Companhia Siderúrgica Nacional (“CSN”) (NYSE: SID) announced today that its subsidiary, CSN Inova Ventures (formerly CSN Islands XI Corp.) (the “Issuer”), an exempted company incorporated under the laws of the Cayman Islands and a direct wholly-owned subsidiary of CSN, has commenced an offer to exchange (the “Exchange Offer”) any and all of its outstanding 6.750% Senior Notes due 2028 (the “2028 Notes”) held by Eligible Holders, as defined below, for the Issuer's 11.000% Senior Notes due 2030 (the “New Notes”) and cash. The 2028 Notes are fully, unconditionally and irrevocably guaranteed by CSN.
Announcement of Private Exchange Offer for Any and All of CSN Inova Ventures' Outstanding 6.750% Senior Notes due 2028 and Consent Solicitation
Negative
Seeking Alpha
1 month ago
Companhia Siderurgica Nacional: The Deleveraging Thesis Has Turned Into A Value Trap
Companhia Siderúrgica Nacional (SID) faces mounting financial stress as organic deleveraging failed and cash burn persisted over four consecutive quarters. SID's reliance on asset sales, notably its cement unit, has become urgent, with proceeds delayed and bridge loans highlighting liquidity pressures. Despite trading at just 0.15x sales and at a 36% discount to the sector on EV/EBITDA, I now see SID as a potential value trap.
Companhia Siderurgica Nacional: The Deleveraging Thesis Has Turned Into A Value Trap
Negative
Zacks Investment Research
4 months ago
National Steel Q1 Earnings Miss Estimates on Softer Steel Demand
SID incurs a loss in Q1 as softer steel demand, imports and weather drag revenues, though EBITDA rises and margins improve.
National Steel Q1 Earnings Miss Estimates on Softer Steel Demand
Positive
MarketBeat
4 months ago
National Steel Q1 Earnings Call Highlights
National Steel NYSE: SID, the Brazilian steelmaker known as CSN, reported higher first-quarter 2026 adjusted EBITDA despite heavy rainfall, a stronger Brazilian real and continued pressure from steel imports in the early part of the year, executives said on the company's earnings call.
National Steel Q1 Earnings Call Highlights
Neutral
Seeking Alpha
4 months ago
Companhia Siderúrgica Nacional (SID) Q1 2026 Earnings Call Transcript
Companhia Siderúrgica Nacional (SID) Q1 2026 Earnings Call Transcript
Companhia Siderúrgica Nacional (SID) Q1 2026 Earnings Call Transcript
Neutral
GlobeNewsWire
4 months ago
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence multiple inflammatory pathways. Data supports potential for soquelitinib to rebalance the immune system and produce drug-free remissions following discontinuation of therapy Immunologic markers consistent with soquelitinib's novel mechanism of action and clinical results SID data included in late-breaking oral presentation; company to review data at investor and analyst meeting today at 1:30 pm ET (12:30 pm CT) SOUTH SAN FRANCISCO, Calif.
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
Neutral
Business Wire
4 months ago
TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DeepBiology--TRexBio to Present Late-Breaking Data at SID 2026 Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis.
TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis
Price charts implemented using Lightweight Charts™